- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06357364
Neural Changes Following Cognitive Behavior Therapy for Procrastination
April 8, 2026 updated by: Nencki Institute of Experimental Biology of the Polish Academy of Sciences
Neural Changes Following Cognitive Behavior Therapy (CBT) for Procrastination: An fMRI and EEG Randomized Controlled Trial of Two CBT Protocols
The aim of this study is to compare the efficacy of and the neural changes following two cognitive behavior therapy (CBT) protocols for procrastination with a wait-list control group.
The interventions will be delivered online in group settings.
Both protocols include identical psychoeducation and cognitive modules aiming at identification and modification of dysfunctional automatic thoughts related to procrastination but will differ in the behavioral modules.
The behavioral module in the first protocol is focused on timely beginning and realistic planning.
The second protocol implements working time restriction.
The wait-list control group will receive one of the CBT protocols after a waiting period that will last as long as the CBT intervention and the assessments performed directly after treatment.
It is assumed that the interventions will be superior to the wait-list control.
Primary (procrastination) and secondary (depression and anxiety) measures will be collected prior to and after the interventions (or waiting period in the wait-list group) and after 6 months in the two active condition groups.
Additionally, neuroimaging measurements will be conducted before and after the interventions (or waiting period in the wait-list group).
Approximately half of the participants will undergo functional Magnetic Resonance Imaging (fMRI), and another half will undergo electroencephalography (EEG).
Both methods are aimed at exploring neural correlates of the expected improvements in participants' self-regulation abilities.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
293
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Warsaw, Poland, 02-093
- Nencki Institute of Experimental Biology, Polish Academy of Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Bachelor's and Master's university students
- Self-reported primary difficulties related to chronic and severe procrastination
- Serious procrastination problem lasting for at least one year as confirmed during clinical interview
- Having a postponed/procrastinated project to complete in the course of therapy
- Willing to participate in the study
- Fluent in Polish language
- Computer access and stable Internet connection
Exclusion Criteria:
- Current participation in other psychotherapy
- Use of psychiatric medication during the last 12 weeks
- Severe anxiety or affective disorders or any other severe psychiatric disorders that require other types of specialized care and are primary to procrastination problem (e.g. major depressive episode, social phobia, PTSD, etc.)
- Active suicidality
- Psychosis, bipolar disorder
- Alcohol or substance dependence
- Severe personality disorders (with the exclusion of avoidant, dependent and obsessive-compulsive personality disorders)
- For Warsaw participants: contradictions for fMRI measurement (metal elements in the body, claustrophobia, neurological conditions, pregnancy etc), non right-handedness.
- For Poznań participants: neurological conditions (e.g. epilepsy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy with Techniques of Starting on Time and Planning Realistically
5 session (one session a week) online group therapy including psychoeducation and cognitive modules (what is procrastination, role of rewards, work environment, identification of dysfunctional automatic thoughts, cognitive restructuring, relapse prevention) and a behavioral module: realistic planning, timely beginning.
|
Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Learning of realistic planning, and timely starting of work.
|
|
Experimental: Cognitive Behavioral Therapy with Technique of Working Time Restriction
5 session (one session a week) online group therapy including psychoeducation and cognitive modules (what is procrastination, role of rewards, work environment, identification of dysfunctional automatic thoughts, cognitive restructuring, relapse prevention) and a behavioral module: working time restriction.
|
Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Restriction of allowed time for work, and gradual increase of allowed time, if previous time windows where effectively used.
|
|
No Intervention: Wait-list control group
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Polish version of the Pure Procrastination Scale (PPS)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of procrastination level.
The Polish version of PPS consists of 12 items that evaluate procrastination conceptualized as a dysfunctional delay (e.g.
"I am continually saying I'll do it tomorrow"; "I delay making decisions until it's too late").
Participants respond on a 5-point scale (1 = "very seldom or not true of me"; 2 = "seldom true of me"; 3 = "sometimes true of me"; 4 = "often true of me"; 5 = "very often true of true of me")
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Aitken Procrastination Inventory (API)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of academic procrastination level.
The Polish version of API consists of 19 items that evaluate the tendency of students to procrastinate in their academic tasks (e.g.
"If I had an important project to do, I'd get started on it as quickly as possible", "Getting down to work often takes me a long time.").
Participants respond on a 5-point scale (1 = "false"; 2 = "mostly false"; 3 = " sometimes false/sometimes true"; 4 = "mostly true"; 5 = "true").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Polish version of the Patient Health Questionnaire (PHQ-9)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of depressive symptoms.
The Polish version of PHQ-9 consists of 9 items that evaluate the occurrence of depressive symptoms in the last 2 weeks (e.g.
"Little interest or enjoyment of your activities").
Participants respond on a 4-point Likert scale (0 = "not at all"; 1 = "on a few days"; 2 = "on more than half of the days"; 3 = "nearly every day").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Generalized Anxiety Disorder Questionnaire-7 (GAD-7)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of anxiety symptoms.
The Polish version of GAD-7 consists of 7 items that evaluate the occurrence of anxiety and excessive worry symptoms in the last 2 weeks (e.g.
"Feeling afraid as if something awful might happen").
Participants respond on a 4-point Likert scale (0 = "not at all"; 1 = "on a few days"; 2 = "on more than half of the days"; 3 = "nearly every day").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Percentage of completion of a particular project that the participant decided to work on during the training (e.g. a thesis, an essay, a report).
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6)
|
Before and after therapy they will be asked to assess the percentage of the project that has been completed.
The higher the difference between the two assessments the better the outcome.
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Polish version of the Credibility Expectancy Questionnaire (CEQ)
Time Frame: After the first session (week 1)
|
After the first session (week 1)
|
|
|
Polish version of the Negative Effects Questionnaire (NEQ)
Time Frame: Post-treatment (week 6)
|
Post-treatment (week 6)
|
|
|
Polish version of the Client Satisfaction Questionnaire (CSQ)
Time Frame: Post-treatment (week 6)
|
Post-treatment (week 6)
|
|
|
Change in Polish version of the Self-control Scale (NAS-50)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire - Short Form (SPSRQ-SF)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Multidimensional-Multiattributional Causality Scale (MMCS)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Performance Failure Appraisal Inventory (PFAI)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Difficulties in Emotion Regulation questionnaire (DERS)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Motivation Diagnostic Test (MDT)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Zimbardo Time Perspective Inventory
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Metacognitive Beliefs about Procrastination Questionnaire (MBPQ)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Impulsivity Scale (UPPS-P)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of the Procrastination Diagnostic Criteria Questionnaires (PDCQ)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
|
Change in Polish version of Positive and Negative Affect Schedule (PANAS) in relation to a project that the participant decided to work on during the training (e.g. a thesis, an essay, a report)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6
|
|
|
Polish version of the Group Session Rating Scale (GSRS)
Time Frame: During the intervention: at the end of every psychotherapy session (weeks 1-5)
|
During the intervention: at the end of every psychotherapy session (weeks 1-5)
|
|
|
Several items concerning homework compliance (cf. Kazantzis et al., 2005).
Time Frame: after sessions 2-5 (weeks 3-6) and at follow-up (6 months after post-treatment assessment)
|
after sessions 2-5 (weeks 3-6) and at follow-up (6 months after post-treatment assessment)
|
|
|
fMRI measurements
Time Frame: baseline assessment (week 0), post-treatment assessment (week 6)
|
Participants from Warsaw, prior to and after the interventions will undergo fMRI measurements, consisting of resting state and two cognitive tasks.
In the first task participants will read sentences representing three conditions: sentences related to academic duties, sentences presenting negative events or situations, and sentences presenting neutral events or situations.
The second task will be a monetary go/no-go task in two conditions: neutral condition, where participants will get some amount of money for each task block, regardless of their performance, and punishment condition, where participants will be given some amount of money prior to each task block, and will lose a fraction of the money each time when they respond to NoGo signal, or when they don't respond to Go signal or respond to it too slow.
|
baseline assessment (week 0), post-treatment assessment (week 6)
|
|
Electroencephalography (EEG) measurements
Time Frame: baseline assessment (week 0), post-treatment assessment (week 6)
|
Participants from Poznań before and after the interventions will undergo electroencephalography (EEG) measurements, during two emo-cognitive tasks.
In the first task, participants will passively view single words related to three conditions: academic procrastination, negative emotions, neutral words.
The second task will be a classic go/no-go task.
In the posttest, there will be an additional negative norm-referenced feedback condition, where participants will be informed that their current performance in the go/no-go task is lower than a certain percentage of people who were tested.
The EEG examination will utilize the Event-Related Potential (ERP) technique to measure the brain's electrical activity in response to specific events (stimuli and responses).
This study will particularly focus on attentional processing and monitoring components, such as the P300, and Error Related Negativity (ERN) and Error Positivity (Pe).
|
baseline assessment (week 0), post-treatment assessment (week 6)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Marek Wypych, PhD, DSc, Nencki Institute of Experimental Biology, Polish Academy of Sciences
- Principal Investigator: Jarosław Michałowski, Prof., SWPS University of Social Sciences and Humanities
- Principal Investigator: Joachim Kowalski, PhD, Institute of Psychology, Polish Academy of Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 8, 2024
Primary Completion (Actual)
January 15, 2026
Study Completion (Actual)
January 15, 2026
Study Registration Dates
First Submitted
March 18, 2024
First Submitted That Met QC Criteria
April 9, 2024
First Posted (Actual)
April 10, 2024
Study Record Updates
Last Update Posted (Actual)
April 9, 2026
Last Update Submitted That Met QC Criteria
April 8, 2026
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- CBT_Procrastination_Neuro
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Procrastination
-
OvercomeCompletedProcrastinationUnited Kingdom
-
University of BarcelonaTerminated
-
University of BathUppsala University; Linkoeping UniversityRecruitingProcrastinationUnited Kingdom
-
VU University of AmsterdamLeiden University; Maastricht University; Utrecht University; Erasmus University...Recruiting
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Nencki Institute of Experimental Biology of the...University of Social Sciences and Humanities, Warsaw; National Science Centre... and other collaboratorsCompleted
-
London Metropolitan UniversityCompletedProcrastinationUnited Kingdom
-
Stockholm UniversityKarolinska InstitutetCompleted
-
Stockholm UniversityCompletedProcrastinationSweden
Clinical Trials on Psychoeducation and cognitive modules
-
NYU Langone HealthRecruitingTraumatic Brain InjuryUnited States
-
Nencki Institute of Experimental Biology of the...University of Social Sciences and Humanities, Warsaw; National Science Centre... and other collaboratorsCompleted
-
Hospital San Carlos, MadridCompleted
-
Medical College of WisconsinTerminatedNeurocognitive DisordersUnited States
-
Université de MontréalCentre de Recherche de l'Institut Universitaire en santé Mentale de MontréalCompleted
-
City University of Hong KongNot yet recruitingMild Cognitive Impairment (MCI)Hong Kong
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
Florida State UniversityUnited States Department of DefenseCompletedDepression | Anxiety | SuicideUnited States
-
Florida State UniversityCompletedSuicide | Health Behavior | Help-Seeking BehaviorUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedStress Disorders, Post-TraumaticUnited States